Hepion Pharmaceuticals에 대한 매도 수량은 투자자에게 Hepion Pharmaceuticals의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Hepion Pharmaceuticals (NASDAQ:HEPA) 주식, 공매도 수량 보고

Hepion Pharmaceuticals

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

Hepion Pharmaceuticals, Inc. - Common Stock

Hepion Pharmaceuticals Inc

Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) has outperformed the market over the past 10 years by 3.31% on an annualized basis producing an average annual return of 15.1%. Currently, Morgan Stanley has a market capitalization of $221.44 billion. 
Buying $100 In MS: If an investor had bought $100 of MS stock 10 years ago, it would be worth $397.58 today based on a price of $137.80 for MS at the time of writing.
<h3>Morgan Stanley's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737671417_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much $100 Invested In Morgan Stanley 10 Years Ago Would Be Worth Today

Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) shares are losing altitude in Thursday&#8217;s after-hours session after the company reported <a href="https://www.benzinga.com/pressreleases/25/01/n43177820/boeing-reports-preliminary-fourth-quarter-results">preliminary fourth-quarter financial results</a>.
What Happened: After the market close on Thursday, Boeing announced that it will recognize impacts to its quarterly results related to the IAM work stoppage and agreement, charges for certain Defense, Space &amp; Security programs and costs associated with workforce reductions from last year.
As a result, the airplane manufacturer now expects to report fourth-quarter revenue of $15.2 billion versus estimates of $16.27 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. Boeing also anticipates a fourth-quarter loss of $5.46 per share.
Operating cash flow is expected to be negative $3.5 billion in the fourth quarter. Boeing said it had $26.3 billion in cash and investments in marketable securities at the quarter&#8217;s end.
&#8220;Although we face near-term challenges, we took important steps to stabilize our business during the quarter including reaching an agreement with our IAM-represented teammates and conducting a successful capital raise to improve our balance sheet,&#8221; said&nbsp;Kelly Ortberg, president and CEO of Boeing.
&#8220;We also restarted 737, 767 and 777/777X production and our team remains focused on the hard work ahead to build a new future for Boeing.&#8221;
BA Price Action: Boeing shares were down 1.43% in after-hours, trading at $175.95 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43177482/trump-signs-executive-order-on-crypto-bitcoin-reserve-to-be-evaluated">Trump Signs Executive Order On Crypto, Bitcoin Reserve To Be &#8216;Evaluated&#8217;</a></li>
</ul>
Photo: Courtesy of Boeing.

Earnings

Guidance

Movers

Boeing Stock Falls On Preliminary Q4 Results: The Details

RFAC

RF Acquisition Says Shareholders Approved Business Combination With GCL Global Holdings At Its Special Meeting

Cryptocurrency markets are trading sideways after a volatile Thursday that saw President Trump sign a <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43177482/trump-signs-executive-order-on-crypto-bitcoin-reserve-to-be-evaluated">crypto-related executive order.</a>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td> $103,650</td>
<td>-0.3%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td> $3,268</td>
<td>+0.3%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td> $248.26</td>
<td>-5.6%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td> $3.10</td>
<td>-2.1%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td> $0.3484</td>
<td>-3.1%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td> $0.00001978</td>
<td>-2.6%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume decreasing by 8.2% and daily active addresses falling by 6.1%. Transactions greater than $100,000 are down from 13,808 to  12,074 in a single day. Exchanges netflows are down by 4.4%.</li>
<li>Coinglass data reports 130,379 traders were liquidated in the past 24 hours for $335.74 million.</li>
<li>Crypto chart analyst Ali Martinez noted that capital inflows into the cryptocurrency market have declined by 63.3% to $43.37 billion since Dec. 10. He <a href="https://x.com/ali_charts/status/1882316333616169360">believes</a> that this suggests a slowdown in market participation and liquidity.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43161311/donald-trump-has-more-than-50-of-net-worth-in-crypto-will-establish-strategic-bitcoin-reserve-anthony-pompliano-predicts">Donald Trump Has &#8216;More Than 50%&#8217; Of Net Worth In Crypto, Will Establish Strategic Bitcoin Reserve, Anthony Pompliano Predicts</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43170775/crypto-senator-lummis-to-chair-senate-banking-digital-assets-subcommittee-is-the-bitcoin-reserve-on-its-way">&#8216;Crypto Senator Lummis&#8217; To Chair Senate Banking Digital Assets Subcommittee: Is The Bitcoin Reserve On Its Way?</a></li>
<li><a href="https://www.benzinga.com/25/01/43151055/sam-altman-founded-world-network-rallies-on-openais-role-in-ai-project-stargate">Sam Altman-Founded Worldcoin Network Rallies, Defying Bitcoin and Ethereum Decline, Amid OpenAI&#8217;s Role in Project Stargate</a></li>
<li><a href="https://www.benzinga.com/25/01/43146179/cryptocurrency-etfs-attract-record-inflows-amid-market-volatility-and-policy-uncertainty">Bitcoin, Ethereum ETFs Attract Record Inflows Despite Market Volatility, Policy Uncertainty</a></li>
</ul>
Top Losers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Fartcoin (CRYPTO: FARTCOIN)</td>
<td>&nbsp;$1.47</td>
<td>-26%</td>
</tr>
<tr>
<td>ai16z (CRYPTO: AI16Z)</td>
<td>&nbsp;$0.8975</td>
<td>-19.5%</td>
</tr>
<tr>
<td>SPX6900 (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">SPX</a>)</td>
<td>&nbsp;$1.26&nbsp;</td>
<td>-13.9%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices relatively flat, crypto trader Seth <a href="https://x.com/seth_fin/status/1882487524393885939">highlighted</a> that Bitcoin is currently at a key resistance level. 
He believes breaking this level could trigger a major pump, remarking that "BTC will salute its new President."
More Crypto Online noted Bitcoin remains in a sideways range despite today's slight upward move. 
Patience is critical until the breakout direction becomes clear.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a>: While there was a nice move to the upside today, the price is still caught in a sideways range. A break below the yellow D-wave now would shift probabilities towards the yellow scenario. A break above $107,250 would confirm the blue scenario further. The manner in which the… <a href="https://t.co/24C4WkuR4J">pic.twitter.com/24C4WkuR4J</a>
&mdash; More Crypto Online (@Morecryptoonl) <a href="https://twitter.com/Morecryptoonl/status/1882494512192253970?ref_src=twsrc%5Etfw">January 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader BitQuant <a href="https://x.com/BitQua/status/1882399598427492668">dismissed</a> claims that Bitcoin has already topped or will peak below $166,000, arguing that such predictions underestimate BTC's potential.
He warned that skeptics risk missing out on substantial gains, even if corrections occur along the way.
Another trader remains bullish, anticipating new all-time highs soon. 
While consolidation above $98,000 may continue, Scient emphasized that holding $99,000 on the 1D chart signals no bearish trends. 
He <a href="https://x.com/Crypto_Scient/status/1882492557231603793">wonders</a> why the crypto timeline is calling for a top in this environment.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43159152/bitcoin-at-102000-but-why-does-the-market-feel-so-bearish">Bitcoin At $102,000 But Why Does The Market Feel So Bearish?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SHIB

$SOL

$SPX

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Flat Despite President Trump Signing Crypto Executive Order

MSBI

Midland States Bancorp Q4 Adj. EPS $(2.52), Down From $0.89 YoY

MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) has outperformed the market over the past 20 years by 13.3% on an annualized basis producing an average annual return of 21.82%. Currently, MicroStrategy has a market capitalization of $91.46 billion. 
Buying $1000 In MSTR: If an investor had bought $1000 of MSTR stock 20 years ago, it would be worth $51,323.25 today based on a price of $371.07 for MSTR at the time of writing.
<h3>MicroStrategy's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737670511_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSTR

$1000 Invested In MicroStrategy 20 Years Ago Would Be Worth This Much Today

This includes a $0.3 billion loss associated with pension plans in the United States, a $0.9 billion gain associated with pension plans outside the United States, and a $0.1 billion gain associated with OPEB plans globally.
&nbsp;The remeasurement gain was largely driven by higher discount rates compared to year-end 2023, partially offset by asset returns lower than our assumptions.&nbsp;
On an after-tax basis, the remeasurement is expected to increase our net income by about $0.4 billion as we expect to recognize a net tax expense based on the tax rates in the jurisdictions where there are remeasurement gains and losses.&nbsp;
Because the remeasurement is a special item, it will not impact total Company adjusted EBIT or adjusted earnings per share. The remeasurement did not have an impact on cash in 2024 and does not change expectations for pension contributions in 2025. In aggregate, funded plans remain fully funded.
Including the impact of remeasurement gains and losses during 2024, Ford expect the underfunded status for pension and OPEB plans to be about $0.5 billion and $4.4 billion, respectively, at year-end 2024, compared with $2.3&nbsp;billion and $4.7 billion, respectively, at year-end 2023.

Ford Expect To Record Pre-tax Remeasurement Gain In Q4 Results Of Approximately $0.7B Related To Pension And OPEB Plans;  No Impact On Adjusted EBIT Or EPS - Filing

Discovery Financial Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>) comfortably beat market expectations in its fourth quarter earnings report.
What Happened: The digital banking and payment services provider achieved a <a href="https://www.benzinga.com/news/earnings/25/01/43148923/discover-delivers-q4-earnings-beat-revenue-beat-the-details">41% growth in net income </a>year over year.
"Despite a modest slowdown in US card sales, overall network volume increased driven by growth in our Pulse business, demonstrating the strength of our payments network," the interim CEO Michael Shepherd <a href="https://investorrelations.discover.com/newsroom/press-releases/default.aspx">said</a> in the earnings call.
Among the streamlining efforts, Shepherd highlighted:
<ul>
<li>$4.5 billion in income stemmed from loan growth, deposit expansion, and an improved net interest margin. </li>
<li>Total loans increased by 3% despite the sale of the student loan portfolio.</li>
<li>Personal loans grew 5% year over year.</li>
</ul>
The results underscore a strong consumer demand for credit, backed by a stable labor market and wage growth outpacing inflation. However, CFO John Greene noted a 3% contraction in Discover card sales, which he attributes to credit-tightening actions going as far as 2022.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43177482/trump-signs-executive-order-on-crypto-bitcoin-reserve-to-be-evaluated">Trump Signs Executive Order On Crypto, Bitcoin Reserve To Be &#8216;Evaluated&#8217;</a>
Why It Matters: Despite this modest slowdown in card sales, the broader trends suggest stability and potential recovery. Payment rates, though slightly down sequentially, remain about 90 basis points above pre-pandemic levels, showing that consumers are still effectively managing their financial obligations.
In a note, Keefe, Bruyette &amp; Woods analysts pointed to the net-interest-margin-driven pre-provision net revenue and highlighted credit quality. They maintained the $232 price target, deriving it from applying the 16x multiple to the 2026 EPS estimate of $14.5. This price target is approximately 15% above today's closing price of $201.20
Last month, Capital One (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) announced the approval of the Office of the Delaware State Bank Commissioner regarding the DFS acquisition. Pending satisfaction of the remaining closing conditions, the all-stock transaction is expected to close early in 2025.
Although the proposed merger drew criticism, particularly from Sen. Elizabeth Waren (D-MA) and Rep. Alexandria Ocasio-Cortez, Shepherd remains undeterred that creating the largest domestic credit card operator is the best course of action.
"We continue to firmly believe that merger will advance our company&#8217;s shared mission to help our customers meet their financial goals, support the communities in which we operate, and create value for our shareholders," he noted.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/01/43172806/tesla-lost-15-billion-in-brand-value-in-2024-report-says-did-elon-musks-political-push-hurt-ev-giant">Tesla Lost $15 Billion In Brand Value In 2024, Report Says: Did Elon Musk&#8217;s Political Push Hurt EV Giant?</a></li>
</ul>
Image: Shutterstock

Earnings Beats

Analyst Ratings

Discovery Financial Services Notches Earnings Beat As Healthy Credit Demand Delivers

Twilio Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) shares are trading higher in Thursday&#8217;s after-hours session after the company provided preliminary financial results <a href="https://www.benzinga.com/pressreleases/25/01/b43052287/twilio-to-announce-fourth-quarter-and-fiscal-year-2024-results-on-february-13-2025">for the fourth quarter</a>.
What Happened: After the market close on Thursday, Twilio introduced new financial expectations in a regulatory filing. The company said it now expects fourth-quarter revenue growth of approximately 11% year-over-year, up from prior guidance of 7% to 8%. 
Twilio said it now expects adjusted income from operations for the fourth quarter to be above the top end of its prior guidance of $185 million to $195 million. The company also anticipates positive GAAP income from operations in the fourth quarter.
Twilio noted that it expects to report free cash flow for full-year 2024 within the range of $650 million to $675 million, which was the guidance range provided in the company&#8217;s third-quarter report.
Twilio is expected to report fourth-quarter financial results after the market close on Feb. 13. Current estimates call for earnings of $1 per share and revenue of $1.16 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
TWLO Price Action: <a href="http://benzinga.com/quote/twlo">Twilio shares</a> were up 9.79% in after-hours, trading at $124.50 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next: • <a href="https://www.benzinga.com/trading-ideas/previews/25/01/43174420/verizon-q4-earnings-preview-company-show-5g-growth-reverse-streak-revenue-misses">Verizon Q4 Earnings Preview: Will Company Show 5G Growth, Reverse Streak Of Revenue Misses?</a>
This illustration was generated using artificial intelligence via Midjourney.

After-Hours Center

TWLO

Twilio Stock Is Trading Higher After-Hours: What's Going On?

First Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRBA#NASDAQ">FRBA</a>) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.39 by 7.69 percent. This is a 14.29 percent decrease over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $33.770 million which beat the analyst consensus estimate of $30.938 million by 9.15 percent. This is a 20.61 percent increase over sales of $27.999 million the same period last year.

FRBA

First Bank Q4 2024 Adj. EPS $0.42 Beats $0.39 Estimate, Sales $33.770M Beat $30.938M Estimate

Tropical Cyclone Sean delivered record rain along parts of the Pilbara coastline of Western Australia, impacting Rio Tinto rail and port operations.
A railcar dumper at the East Intercourse Island (EII) port facility, which shipped 45 million tonnes of total Rio Tinto Iron Ore shipments in 2024, was flooded after the weather event passed the coast, delivering 274mm to Karratha during January 20, 2025.
The company is working to mitigate impacts and will provide an update at its full year results on 19 February 2025.

Rio Tinto Provides Iron Ore Update After Tropical Cyclone Sean; Q1 Shipments Will Be Affected, Overall Shipment Guidance For 2025 Remains Unchanged

First Western Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYFW#NASDAQ">MYFW</a>) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.26 by 7.69 percent. The company reported quarterly sales of $23.367 million which missed the analyst consensus estimate of $24.412 million by 4.28 percent. This is a 4.26 percent increase over sales of $22.412 million the same period last year.

Earnings Misses

MYFW

First Western Financial Q4 2024 GAAP EPS $0.28 Beats $0.26 Estimate, Sales $23.367M Miss $24.412M Estimate

Netflix Hits All-Time Highs: Could Another Stock Split Be On The Horizon?
Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) stock hit all-time highs Wednesday after the company reported fourth-quarter financial results that <a href="https://www.benzinga.com/general/entertainment/25/01/43136402/netflix-stock-firing-on-all-cylinders-10-analysts-react-to-q4-beat-guidance-price-increases">beat analyst estimates.</a>
With plenty of attention shifting to the 2025 content lineup, investors are also questioning if Netflix will split shares once again.
What Happened: Netflix <a href="https://www.benzinga.com/news/earnings/25/01/43114866/netflix-q4-earnings-record-subscribers-nfl-squid-game-push-past-highest-expectations">announced it added </a>18.91 million net new paid subscribers in the fourth quarter, its best quarterly member gain ever.
The company will no longer share key metrics, including membership gains and total members going forward, which could put more pressure on the company's revenue and earnings per share figures to keep investors happy.
Another way to keep investors happy in 2025 could be a stock split. While a stock split wouldn't change the value of the company, the move could make shares more attractive to retail investors looking to accumulate whole shares and not fractional shares and to options traders.
Benzinga reached out to Netflix for comment on a potential stock split and did not hear back.
Netflix went public in May 2002 at <a href="https://www.benzinga.com/general/entertainment/24/04/38340753/if-you-invested-1-000-in-netflix-stock-at-its-ipo-heres-how-much-youd-have-today">$15 per share.</a> The company has split shares two times in its history, a 2-for-1 split in February 2004 and a seven-for-one split in July 2015.
Read Also: <a href="https://www.benzinga.com/general/education/25/01/43145703/netflix-worth-more-than-disney-paramount-comcast-fox-combined">Netflix Worth More Than Disney, Paramount, Comcast, Fox Combined</a>
Why It's Important: Netflix's first stock split came in 2004 when the company was still renting DVDs through the mail to customers and competing with physical DVD rental chains like Blockbuster, which later went bankrupt in 2010.
That stock split happened when shares were trading at around $72.
The 2015 stock split came years after the company entered the streaming sector and had launched several of its own original series, including "Lillyhammer," and "House of Cards."
This stock split came when shares traded at around $700.
As shares soared over $700 in late 2024, investors began asking if another stock split could happen.
The company highlighted its strong fourth-quarter membership adds and its 2025 content slate that includes new seasons of "Squid Game," "Stranger Things" and "Wednesday."
Without reporting some of the normal membership metrics, investors could grow impatient and be looking for new catalysts from the company. A stock split could act as another catalyst for investors.
Netflix stock opened for trading at a split-adjusted $111.02 on July 16, 2015, after the seven-for-one split. A $1,000 investment at the time could have bought 9.01 Netflix shares. Today, that $1,000 investment would be worth $8,834.49, up 783.4%.
While the same returns aren't guaranteed if Netflix splits their stock, investors will be closely watching.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42751367/netflix-posts-record-debut-with-squid-game-season-2-heres-how-many-people-watched-show">Netflix Posts Record Debut With &#8216;Squid Game&#8217; Season 2: Here&#8217;s How Many People Watched Show</a></li>
</ul>
Photo: Shutterstock

Entertainment

NFLX

Netflix Hits All-Time Highs: Could Another Stock Split Be On The Horizon?

The Company notified the NYSE on January&nbsp;3, 2025 of its intention to cure such deficiency. In accordance with NYSE listing requirements, the Company has 90 calendar days from the receipt of the Notice to respond with a business plan that demonstrates compliance with this continued listing standard within 18 months of receipt of the Notice.&nbsp;

LITB

LightInTheBox Gets NYSE Non-Compliance Letter Regarding Market Capitalization

7 analysts have expressed a variety of opinions on Topgolf Callaway Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MODG#NYSE">MODG</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $12.43, along with a high estimate of $16.00 and a low estimate of $9.00. Observing a downward trend, the current average is 9.34% lower than the prior average price target of $13.71. 
<img src="https://www.benzinga.com/files/images/story/2025/1737669692_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Topgolf Callaway Brands. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$9.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Michael Swartz</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$12.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Randal Konik</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>George Kelly</td>
<td>Roth MKM</td>
<td>Lowers</td>
<td>Buy</td>
<td>$16.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$12.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Michael Swartz</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$14.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$11.00</td>
<td>$13.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Topgolf Callaway Brands. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Topgolf Callaway Brands compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Topgolf Callaway Brands's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Topgolf Callaway Brands's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/MODG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Topgolf Callaway Brands analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Topgolf Callaway Brands's Background</h2>
Topgolf Callaway Brands Corp is a modern golf and active lifestyle company that provides world-class golf entertainment experiences, designs and manufactures premium golf equipment, and sells golf and active lifestyle apparel and other accessories through brands such as, Topgolf, Callaway Golf, Odyssey, TravisMathew, Jack Wolfskin, OGIO and Toptracer. The company's reportable segments are; Topgolf, Golf Equipment and Active Lifestyle. Majority of the revenue is generated from its Topgolf segment which is predominantly comprised of service revenues and expenses from the company operated Topgolf venues, Toptracer ball-flight tracking technology, and WGT digital golf game. Geographically, majority of the revenue for the company is derived from United States.
<h3>Unraveling the Financial Story of Topgolf Callaway Brands</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Topgolf Callaway Brands's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -2.66%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -0.36%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -0.09%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Topgolf Callaway Brands's ROA stands out, surpassing industry averages. With an impressive ROA of -0.04%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Topgolf Callaway Brands's debt-to-equity ratio stands notably higher than the industry average, reaching 0.76. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MODG

Beyond The Numbers: 7 Analysts Discuss Topgolf Callaway Brands Stock

In the preceding three months, 13 analysts have released ratings for Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>), presenting a wide array of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">10</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Guidewire Software, presenting an average target of $221.54, a high estimate of $231.00, and a low estimate of $210.00. Marking an increase of 5.28%, the current average surpasses the previous average price target of $210.42. 
<img src="https://www.benzinga.com/files/images/story/2025/1737669684_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Guidewire Software. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Adam Hotchkiss</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$210.00</td>
<td>-</td>
</tr>
<tr>
<td>Ken Wong</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$230.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Alexei Gogolev</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$228.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$230.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$220.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Aaron Kimson</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$231.00</td>
<td>$231.00</td>
</tr>
<tr>
<td>Peter Heckmann</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Joe Goodwin</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$231.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$215.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$215.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Parker Lane</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$220.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Joe Vruwink</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$220.00</td>
<td>$204.00</td>
</tr>
<tr>
<td>Ken Wong</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$220.00</td>
<td>$200.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Guidewire Software. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Guidewire Software compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Guidewire Software's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Guidewire Software's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/GWRE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Guidewire Software analyst ratings.</a>
<h2>Unveiling the Story Behind Guidewire Software</h2>
Guidewire Software provides software solutions for property and casualty insurers. Flagship product InsuranceSuite is an on-premises system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a cloud-based offering, as well as a variety of other add-on applications.
<h3>Financial Milestones: Guidewire Software's Journey</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Guidewire Software's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 26.76% as of 31 October, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Guidewire Software's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 3.48%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Guidewire Software's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.7%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Guidewire Software's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.38%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Guidewire Software's debt-to-equity ratio surpasses industry norms, standing at 0.78. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GWRE

A Glimpse Into The Expert Outlook On Guidewire Software Through 13 Analysts

4 analysts have shared their evaluations of Cadence Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CADE#NYSE">CADE</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $43.0, a high estimate of $45.00, and a low estimate of $41.00. Surpassing the previous average price target of $39.50, the current average has increased by 8.86%.
<img src="https://www.benzinga.com/files/images/story/2025/1737669672_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A comprehensive examination of how financial experts perceive Cadence Bank is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matt Olney</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$42.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Jared Shaw</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$44.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Jared Shaw</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$41.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Catherine Mealor</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$38.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Cadence Bank. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Cadence Bank compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Cadence Bank's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Cadence Bank's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CADE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Cadence Bank analyst ratings.</a>
<h2>Get to Know Cadence Bank Better</h2>
Cadence Bank is a bank based in the United States. The operating segments are Corporate Banking segment focuses on C&amp;I, business banking, and commercial real estate lending to clients in the geographic footprint, Community Banking segment provides a broad range of banking services through the branch network to serve the needs of community businesses and individual consumers in the geographic footprint, Mortgage segment includes mortgage banking activities of originating mortgage loans, selling mortgage loans in the secondary market and servicing the mortgage loans, Banking Services segment offers individuals, businesses, governmental institutions, and non-profit entities a widerange of solutions to help protect, grow, and transfer wealth, General Corporate and Other segment.
<h3>Unraveling the Financial Story of Cadence Bank</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Cadence Bank's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 11.02%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Cadence Bank's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 29.97%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Cadence Bank's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.55%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Cadence Bank's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.28%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Cadence Bank's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.69, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CADE

Cadence Bank Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Redwood Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RWT#NYSE">RWT</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Redwood Trust, presenting an average target of $7.38, a high estimate of $8.00, and a low estimate of $6.50. This current average has decreased by 6.46% from the previous average price target of $7.89. 
<img src="https://www.benzinga.com/files/images/story/2025/1737669665_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Redwood Trust's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chris Muller</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$8.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$6.50</td>
<td>$7.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$7.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Jason Weaver</td>
<td>Jones Trading</td>
<td>Raises</td>
<td>Buy</td>
<td>$8.00</td>
<td>$7.55</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Redwood Trust. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Redwood Trust compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Redwood Trust's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Redwood Trust's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RWT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Redwood Trust analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Redwood Trust</h2>
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: the Residential Consumer Mortgage Banking segment consists of a mortgage loan conduit that acquires residential loans from third-party originators for subsequent sale to whole loan buyers, securitization through SEMT (Sequoia) private-label securitization program, or transfer into its investment portfolio, Residential Investor Mortgage Banking segment consists of a platform that originates and acquires business purpose lending loans for subsequent securitization, sale, or transfers into its investment portfolio, and Investment Portfolio segment consists of organic investments sourced through residential and business-purpose mortgage banking operations.
<h3>Unraveling the Financial Story of Redwood Trust</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Redwood Trust's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 1053.95%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Redwood Trust's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 21.72%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Redwood Trust's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.13% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Redwood Trust's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.07%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 14.56, caution is advised due to increased financial risk.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Redwood Trust: Insights From 4 Financial Analysts

Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>) has been analyzed by 10 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $52.0, along with a high estimate of $56.00 and a low estimate of $47.00. This current average has increased by 6.12% from the previous average price target of $49.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1737669657_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Fifth Third Bancorp. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Winter</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Gerard Cassidy</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$47.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Scott Siefers</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$53.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Brian Foran</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$52.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Brian Foran</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$51.00</td>
<td>-</td>
</tr>
<tr>
<td>Jason Goldberg</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$56.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>David Konrad</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$51.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Scott Siefers</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Keith Horowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$52.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Whit Mayo</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$52.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Fifth Third Bancorp. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Fifth Third Bancorp compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Fifth Third Bancorp's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Fifth Third Bancorp's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FITB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Fifth Third Bancorp analyst ratings.</a>
<h2>All You Need to Know About Fifth Third Bancorp</h2>
Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $200 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.
<h3>Fifth Third Bancorp's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Fifth Third Bancorp's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 4.12%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Fifth Third Bancorp's net margin is impressive, surpassing industry averages. With a net margin of 27.1%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Fifth Third Bancorp's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 3.22%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.27%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Fifth Third Bancorp's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.07.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FITB

Analyst Expectations For Fifth Third Bancorp's Future

Across the recent three months, 4 analysts have shared their insights on Pacific Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $3.06, a high estimate of $6.00, and a low estimate of $1.75. This current average has decreased by 18.4% from the previous average price target of $3.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1737669645_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Pacific Biosciences. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Sykes</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$1.75</td>
<td>$2.25</td>
</tr>
<tr>
<td>John Sourbeer</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$2.00</td>
<td>-</td>
</tr>
<tr>
<td>Sung Ji Nam</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$6.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>David Westenberg</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$2.50</td>
<td>$2.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Pacific Biosciences. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Pacific Biosciences compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Pacific Biosciences's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Pacific Biosciences's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PACB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Pacific Biosciences analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Discovering Pacific Biosciences: A Closer Look</h2>
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
<h3>Financial Milestones: Pacific Biosciences's Journey</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining Pacific Biosciences's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -28.23% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Pacific Biosciences's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -151.94% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Pacific Biosciences's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -12.84%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Pacific Biosciences's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -4.1%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Pacific Biosciences's debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.03, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PACB

What Analysts Are Saying About Pacific Biosciences Stock

Pharma Two B and Hepion Pharmaceuticals (HEPA) announced that the U.S. Securities and Exchange Commission has declared effective the registration s...

Hepion, Pharma Two B announce effectiveness of registration statement for merger

Hepion Pharmaceuticals (HEPA) has sent an open letter to shareholders urging them to vote for Hepion's proposed merger with Pharma Two B Ltd. at th...

Hepion Pharmaceuticals' shareholder letter urging support for Pharma Two B deal

Pharma Two B announced a poster presentation of integrated safety and efficacy data on P2B001 from its Phase 2b and Phase 3 studies in early-stage ...

Pharma Two B announces poster presentation on P2B001

Hepion Pharmaceuticals announces termination of merger agreement with Pharma Two B

Hepion Pharmaceuticals ( ($HEPA) ) just unveiled an announcement. Hepion Pharmaceuticals announced the mutual termination of its merger agreement w...

Hepion Pharmaceuticals Terminates Merger with Pharma Two B

Key deals for the week: Patterson, Hershey & Mondelez, AIG & Nippon and more

Hepion Pharmaceuticals files to sell common stock, warrants

Laidlaw & Company is sole placement agent. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Tr...

Hepion Pharmaceuticals files to sell common stock, warrants, no amount given

Hepion Pharmaceuticals (HEPA) announced the launch of a "best efforts" public offering of 27,692,310 shares of common stock with each share of comm...

Hepion Pharmaceuticals announces $9M public offering

Hepion Pharmaceuticals launches public offering for proceeds of up to $9M; shares tumble

AMCR

BERY

CRBG

CTLT

EEFT

HEPA

HURA

MDLZ

PDCO

PTVE

RVNC

SNPS

TMVWF

TMVWY

TUWLF

UPBD

Press Releases

Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds

Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell

Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b 'ASCEND-NASH' Trial

Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Health Care

General

Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson's Disease Study Group

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

Hepion Pharmaceuticals Announces $9.0 Million Public Offering

Akanda

Enveric Biosciences

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharma

Petros Pharmaceuticals, Inc. - Common Stock

Petros Pharma

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

TNF Pharmaceuticals

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharma

Universe Pharmaceuticals Inc - Ordinary Shares

Comments

Hepion Pharmaceuticals

매도 수량

Hepion Pharmaceuticals (NASDAQ:HEPA) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌